Lucid Diagnostics Inc. (NASDAQ: LUCD) reported Q3 EPS of ($0.22), in-line with the analyst estimate of ($0.22). Revenue for the quarter came in at $800 thousand versus the consensus estimate of $792.69 thousand.

For earnings history and earnings-related data on Lucid Diagnostics Inc. (LUCD) click here.